ATG4B and neoplasm: Second, the apparent parallel modulation of ATG-4B by both BCc1 and cyclophosphamide suggests a potential pharmacodynamic convergence that could be strategically leveraged in combination regimens to achieve synergistic targeting of autophagy-dependent tumor resilience.